drugset / Trial / NCT00191750

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

NCT00191750 ↗

Phase 2 Completed 80 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purposes of this study are to determine 1) the safety of pemetrexed and any side effects that might be associated with it 2) whether pemetrexed can help patients with small cell lung cancer live longer 3) whether pemetrexed can make tumors smaller or disappear and for how long and 4) to see if patients feel better while taking pemetrexed

Timeline

Start
2004-07
Primary completion
—
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule — —